InChI=1S/C17H18N4O4/c1- 10(22) 21- 13(11- 7- 5- 4- 6- 8- 11) 9- 12(18- 21) 14- 15(23) 19(2) 17(25) 20(3) 16(14) 24/h4- 8,13,18H,9H2,1- 3H3 |
HPCIYRPJQBJFFL-UHFFFAOYSA-N |
CC(=O)N1C(CC(=C2C(=O)N(C(=O)N(C2=O)C)C)N1)C3=CC=CC=C3 |
|
GABA modulator
A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act.
(via barbiturates )
|
|
GABA modulator
A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act.
(via barbiturates )
|
|
View more via ChEBI Ontology
Outgoing
|
5-(1-acetyl-5-phenyl-3-pyrazolidinylidene)-1,3-dimethyl-1,3-diazinane-2,4,6-trione
(CHEBI:105047)
is a
barbiturates
(CHEBI:22693)
|
|
|